BRPI0908197A2 - antígenos recombinantes - Google Patents

antígenos recombinantes

Info

Publication number
BRPI0908197A2
BRPI0908197A2 BRPI0908197A BRPI0908197A BRPI0908197A2 BR PI0908197 A2 BRPI0908197 A2 BR PI0908197A2 BR PI0908197 A BRPI0908197 A BR PI0908197A BR PI0908197 A BRPI0908197 A BR PI0908197A BR PI0908197 A2 BRPI0908197 A2 BR PI0908197A2
Authority
BR
Brazil
Prior art keywords
recombinant antigens
antigens
recombinant
Prior art date
Application number
BRPI0908197A
Other languages
English (en)
Inventor
Antonio Osuna Carrilo De Albornoz
Fátima Brazil Dos Santos
Jennifer Solano Parada
Miguel Burgos Poyatos
Original Assignee
Univ Granada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Granada filed Critical Univ Granada
Publication of BRPI0908197A2 publication Critical patent/BRPI0908197A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
BRPI0908197A 2008-02-27 2009-02-19 antígenos recombinantes BRPI0908197A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200800565A ES2325243B1 (es) 2008-02-27 2008-02-27 Antigeno recombinante.
PCT/ES2009/070036 WO2009106666A1 (es) 2008-02-27 2009-02-19 Antigeno recombinante

Publications (1)

Publication Number Publication Date
BRPI0908197A2 true BRPI0908197A2 (pt) 2016-07-05

Family

ID=40951217

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0908197A BRPI0908197A2 (pt) 2008-02-27 2009-02-19 antígenos recombinantes

Country Status (7)

Country Link
US (1) US8821886B2 (pt)
EP (1) EP2264057A4 (pt)
AU (1) AU2009218374A1 (pt)
BR (1) BRPI0908197A2 (pt)
ES (1) ES2325243B1 (pt)
NZ (1) NZ588270A (pt)
WO (1) WO2009106666A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3468530A4 (en) * 2016-06-10 2020-03-11 Clarity Cosmetics Inc. NON-COMEDOGEN FORMULA FOR HAIR AND SCALP CARE AND METHOD FOR USE

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ230747A (en) 1988-09-30 1992-05-26 Bror Morein Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina
GB9209993D0 (en) 1992-05-08 1992-06-24 Munn Edward A Vaccines
US5955089A (en) * 1993-04-20 1999-09-21 Uab Research Foundation Strain selection of pneumococcal surface proteins
SE9600646D0 (sv) 1996-02-21 1996-02-21 Bror Morein Vaccin
SE9600647D0 (sv) * 1996-02-21 1996-02-21 Bror Morein Ny användning
SE9600648D0 (sv) * 1996-02-21 1996-02-21 Bror Morein Receptorbimdande enhet
US6464979B1 (en) * 1996-09-12 2002-10-15 Aventis Pasteur Limited Chlamydial vaccines and methods of preparation thereof
US6747137B1 (en) * 1998-02-13 2004-06-08 Genome Therapeutics Corporation Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics
GB9817052D0 (en) 1998-08-05 1998-09-30 Smithkline Beecham Biolog Vaccine

Also Published As

Publication number Publication date
EP2264057A4 (en) 2012-05-09
ES2325243A1 (es) 2009-08-28
ES2325243B1 (es) 2011-05-04
US20110123519A1 (en) 2011-05-26
EP2264057A1 (en) 2010-12-22
NZ588270A (en) 2014-04-30
US8821886B2 (en) 2014-09-02
AU2009218374A1 (en) 2009-09-03
WO2009106666A1 (es) 2009-09-03

Similar Documents

Publication Publication Date Title
EP2276499A4 (en) ANTIGEN OF RECOMBINANT GLIADINE DEAMIDED
CY2019004I2 (el) Τροποποιημενα αντισωματα αντι-ιl-23ρ19
BRPI0906877A2 (pt) Anticorpos anti-trkb aperfeiçoados
BRPI0907237A2 (pt) Anticorpo anti-cldn6
HRP20171011T1 (hr) ANTI-eMET ANTITIJELO
IL212175B (en) Muc1* antibodies
PT2406284T (pt) Anticorpos anti-bcma
HUE056626T2 (hu) Antitestkészítmény
PT2813570T (pt) Resumo
EP2303378A4 (en) INTERFACE
PT2406399T (pt) Proteínas mirac
PL2465864T3 (pl) Szczepionki z peptydem pochodzącym z Eph4
BRPI0911604A2 (pt) vacinas de polipeptídeo de flagelina
BRPI0912173A2 (pt) anticorpos anti-flt3
BRPI0917148A2 (pt) anticorpos anti-cd5
PT3045471T (pt) Resumo
EP2377932A4 (en) ANTI-Siglec-15 ANTIBODY
BRPI0923359A2 (pt) Anticorpos anti-igf
DK2370462T3 (da) Glucagon-analoger
DK2342317T3 (da) Hængende-dråbe-plade
BRPI0907376A2 (pt) Fotobiorretador
EP2207803A4 (en) Cd9-specific human antibodies
BRPI0909633A2 (pt) anticorpos anti-tyrp1
CR10821S (es) Marmita al vacio
BRPI0915367A2 (pt) peptídeos e epítopos anti-p2x7

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2502 DE 18-12-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]